WallStreetZenWallStreetZen

NASDAQ: LXEO
Lexeo Therapeutics Inc Stock Ownership - Who owns Lexeo Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Lexeo Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jenny RobertsonChief Legal Officer2025-03-145,720$2.61
$14.93kBuy
Jose Manuel OteroChief Technical Officer2025-03-145,720$2.61
$14.93kBuy
Tai Sandi SeeChief Development Officer2025-03-145,720$2.61
$14.93kBuy
Richard Nolan TownsendChief Executive Officer2025-03-142,128$2.61
$5.55kBuy
Eric AdlerChief Medical Officer2025-02-192,359$4.41
$10.41kSell
Jenny RobertsonChief Legal Officer2025-02-192,101$4.41
$9.27kSell
Tai Sandi SeeChief Development Officer2025-02-191,486$4.41
$6.56kSell
Richard Nolan TownsendChief Executive Officer2025-02-194,326$4.41
$19.09kSell
Richard Nolan TownsendChief Executive Officer2024-12-102,500$2.33
$5.83kBuy
Richard Nolan TownsendChief Executive Officer2024-12-102,500$8.20
$20.49kSell

1 of 3

LXEO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LXEO insiders and whales buy or sell their stock.

LXEO Shareholders

What type of owners hold Lexeo Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Janus Henderson Group PLC13.07%4,339,254$11.76MInstitution
Citadel Advisors LLC8.20%2,723,363$7.38MInstitution
Longitude Capital Partners IV LLC7.73%2,567,100$6.96MInsider
Adage Capital Partners GP LLC6.66%2,209,615$5.99MInstitution
D1 Capital Partners LP6.64%2,203,900$5.97MInstitution
Omega Fund VI LP6.50%2,157,623$5.85MInsider
Invest A. Lundbeckfond5.53%1,835,959$4.98MInsider
Blackrock Inc5.49%1,821,966$4.94MInstitution
Eventide Asset Management LLC3.72%1,234,834$3.35MInstitution
Vestal Point Capital LP3.61%1,200,000$3.25MInstitution

1 of 3

LXEO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LXEO80.55%19.45%Net SellingNet Buying
NMRA33.69%66.31%Net SellingNet Selling
TIL6.44%93.56%
OBIO42.93%57.07%Net SellingNet Selling
CSBR1.94%98.06%Net Buying
View Top Biotech Stocks

Lexeo Therapeutics Stock Ownership FAQ

Who owns Lexeo Therapeutics?

Lexeo Therapeutics (NASDAQ: LXEO) is owned by 88.92% institutional shareholders, 21.47% Lexeo Therapeutics insiders, and 0.00% retail investors. Longitude Capital Partners IV LLC is the largest individual Lexeo Therapeutics shareholder, owning 2.57M shares representing 7.73% of the company. Longitude Capital Partners IV LLC's Lexeo Therapeutics shares are currently valued at $8.24M.

If you're new to stock investing, here's how to buy Lexeo Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.